50881-028 : Pemazyre 13.5 mg Oral Tablet
| NDC: | 50881-028 |
| Labeler: | Incyte Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Pemazyre |
| Dosage Form: | Oral Tablet |
| Application #: | NDA213736 |
| Rev. Date: |
Appearance:
| Markings: | I;135 |
| Shapes: |
Round |
| Colors: |
 White |
| Size (mm): | 9 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 50881-028-01: 14 TABLET IN 1 BOTTLE, PLASTIC (50881‑028‑01)
Active Ingredients:
- Pemigatinib
Dosage Strength:
- 13.5 mg
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
- Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
- Organic Cation Transporter 2 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 50881-026 Pemazyre 4.5 mg Oral Tablet by Incyte Corporation
- 50881-027 Pemazyre 9 mg Oral Tablet by Incyte Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50881-027Next: 50914-7720 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.